This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hasche, E. T. Articles by Jeremy, R. W. Search for Related Content PubMed PubMed Citation Articles by Hasche, E. T. Articles by Jeremy, R. W.

(Circulation. 1995;92:710-719.)
© 1995 American Heart Association, Inc.

Articles

Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans

Edmund T. Hasche, MBBS; Clyne Fernandes, MBBS; S. Ben Freedman, MBBS, PhD; Richmond W. Jeremy, MBBS, PhD

From the Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.

Correspondence to Dr Richmond W. Jeremy, Department of Cardiology, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, 2050, New South Wales, Australia.

Background Experimental studies indicate that duration of ischemia is a major determinant of myocardial infarct size, but only limited information is available about the relation between ischemia time and infarct size in individual patients. This prospective study sought to document the role of ischemia time as a determinant of infarct size in humans.

Methods and Results We studied 61 patients (50 men, 11 women) 57±11 years old admitted with a first infarct (31 anterior, 30 inferior) who underwent continuous 12-lead ECG monitoring to document ischemia time. Infarct size (32-point QRS score on day 7) and changes in regional myocardial wall motion (echocardiography) during the following month were related to ischemia time. Among patients with <3 hours of ischemia (n=16), mean infarct size on day 7 was 21±13% of potential infarct size; in patients with 3 to 6 hours of ischemia (n=23), infarct size was 38±18% of potential (P<.05 versus 0 to 3 hours of ischemia); and in patients with 6 to 9 hours of ischemia (n=10), infarct size was 66±14% of potential (P<.05 versus 3 to 6 hours). In contrast, the 12 patients with an ischemia time >9 hours had a final infarct size of 77±10% of potential (P<.01 versus 3 to 6 hours). Multivariate regression identified size of risk region, duration of ischemia, and degree of initial ST-segment elevation as independent predictors of infarct size, of which the most important variable was ischemia time. The regression models accurately predicted both individual absolute infarct size (R²=.83) and individual infarct/risk ratio (R²=.74). Patients with <6 hours of ischemia exhibited significant recovery of myocardial wall motion by day 7 (wall motion score, 2.1±1.4 versus 5.7±3.2 on day 1, P<.01). Patients with 6 to 9 hours of ischemia had some recovery by 1 month (score, 6.3±4.4 versus 10.9±3.8 on day 1, P<.01), but patients with >9 hours of ischemia had little recovery of wall motion by 1 month (score, 10.3±4.5 versus 12.8±3.1 on day 1, P<.05).

Conclusions Measurement of ischemia time allows improved prediction of infarct size in humans. Significant myocardial salvage and functional recovery may be achieved by reperfusion up to 9 hours after coronary occlusion. Continuous ST-segment monitoring should be used to measure ischemia time and guide interventions to reperfuse the infarct artery.

Key Words: myocardial infarction • reperfusion • ischemia • electrocardiography

This article has been cited by other articles:

				Y Birnbaum and B J Drew The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis Postgrad. Med. J., September 1, 2003; 79(935): 490 - 504. [Abstract] [Full Text]

				P. Widimsky, T. Budesinsky, D. Vorac, L. Groch, M. Zelizko, M. Aschermann, M. Branny, J. St'asek, P. Formanek, and on behalf of the 'PRAGUE' Study Group Investigator Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial--PRAGUE-2 Eur. Heart J., January 1, 2003; 24(1): 94 - 104. [Abstract] [Full Text] [PDF]

				P Lancellotti, A Albert, C Berthe, and L A Piérard Full recovery of contraction late after acute myocardial infarction: determinants and early predictors Heart, May 1, 2001; 85(5): 521 - 526. [Abstract] [Full Text]

				M. Saeed, G. Lund, M. F. Wendland, J. Bremerich, H.-J. Weinmann, and C. B. Higgins Magnetic Resonance Characterization of the Peri-Infarction Zone of Reperfused Myocardial Infarction With Necrosis-Specific and Extracellular Nonspecific Contrast Media Circulation, February 13, 2001; 103(6): 871 - 876. [Abstract] [Full Text] [PDF]

				P. Widimsky, L. Groch, M. Zelizko, M. Aschermann, F. Bednar, and H. Suryapranata Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study Eur. Heart J., May 2, 2000; 21(10): 823 - 831. [Abstract] [PDF]

				M. Kondo, A. Nakano, D. Saito, and Y. Shimono Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 898 - 903. [Abstract] [Full Text] [PDF]